The mineralocorticoid receptor blocker spironolactone lowers plasma interferon-γ and interleukin-6 in patients with type 2 diabetes and treatment-resistant hypertension

Sai Sindhu Thangaraj^*, Christina Stolzenburg Oxlund, Micaella Pereira Da Fonseca, Per Svenningsen, Jane Stubbe, Yaseelan Palarasah, Daniel F J Ketelhuth, Ib Abildgaard Jacobsen, Boye L Jensen

^*Corresponding author for this work

Research output: Contribution to journal › Journal article › Research › peer-review

1 Ph.D. thesis

1 results

2022
Promotion of hypertension and end-organ injury by Interleukin 17A mediated by Aldosterone-MR and ENaC
Thangaraj, S. S., 11. Apr 2022, Syddansk Universitet. Det Sundhedsvidenskabelige Fakultet. 183 p.
Research output: Thesis › Ph.D. thesis

Open Access
File
148 Downloads (Pure)